Schisandrin A inhibited MAPK and NF-B signaling pathways to reduce inflammation and cartilage degradation induced by IL-1, thus playing a therapeutic role in osteoarthritis (54)
A consultation confirms which path fits your health history
In 2017, the Food and Drug Administration approved a new iteration, Ozempic (semaglutide), as a T2D treatment
Getting rid of your belly bulge is important for more than just looks it reduces your risk of type 2 diabetes, high blood pressure, cardiovascular disease, and even colorectal cancer
The Microdose approach allows patients to start at lower initial doses, reducing nausea and gastrointestinal side effects while your body adjusts to GLP-1 therapy
At the same time, thyroid function may downregulate to conserve energy, leading to symptoms like feeling cold all the time, sluggishness, or brain fog